|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/07/24 Aldeyra Therapeutics, Inc. 10-K 12/31/23 78:10M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 2.25M
2: EX-10.14 Material Contract HTML 45K
3: EX-10.26 Material Contract HTML 1.12M
4: EX-21.1 Subsidiaries List HTML 24K
5: EX-23.1 Consent of Expert or Counsel HTML 22K
9: EX-97 Clawback Policy re: Recovery of Erroneously HTML 48K
Awarded Compensation
6: EX-31.1 Certification -- §302 - SOA'02 HTML 27K
7: EX-31.2 Certification -- §302 - SOA'02 HTML 27K
8: EX-32.1 Certification -- §906 - SOA'02 HTML 27K
11: R1 Document And Entity Information HTML 96K
12: R2 Consolidated Balance Sheets HTML 112K
13: R3 Consolidated Balance Sheets (Parenthetical) HTML 43K
14: R4 Consolidated Statements of Operations HTML 70K
15: R5 Consolidated Statements of Comprehensive Loss HTML 51K
16: R6 Consolidated Statements of Stockholders' Equity HTML 74K
17: R7 Consolidated Statements of Cash Flows HTML 92K
18: R8 Pay vs Performance Disclosure HTML 34K
19: R9 Insider Trading Arrangements HTML 32K
20: R10 Nature of Business HTML 27K
21: R11 Basis of Presentation and Significant Accounting HTML 63K
Policies
22: R12 Helio vision acquisition HTML 32K
23: R13 Net Loss Per Share HTML 36K
24: R14 Cash, Cash Equivalents and Marketable Securities HTML 88K
25: R15 Fair Value Measurements HTML 69K
26: R16 Prepaid expenses and other current assets HTML 41K
27: R17 Accrued Expenses HTML 38K
28: R18 Credit Facility HTML 65K
29: R19 Stockholders' Equity HTML 33K
30: R20 Income Taxes HTML 114K
31: R21 Stock Incentive Plan HTML 149K
32: R22 Commitments and Contingencies HTML 37K
33: R23 Leases HTML 52K
34: R24 Significant Agreements HTML 31K
35: R25 Basis of Presentation and Significant Accounting HTML 101K
Policies (Policies)
36: R26 Net Loss Per Share (Tables) HTML 35K
37: R27 Cash, Cash Equivalents and Marketable Securities HTML 87K
(Tables)
38: R28 Fair Value Measurements (Tables) HTML 64K
39: R29 Prepaid expenses and other current assets (Tables) HTML 40K
40: R30 Accrued Expenses (Tables) HTML 37K
41: R31 Credit Facility (Tables) HTML 51K
42: R32 Income Taxes (Tables) HTML 103K
43: R33 Stock Incentive Plan (Tables) HTML 132K
44: R34 Leases (Tables) HTML 47K
45: R35 Basis of Presentation and Significant Accounting HTML 53K
Policies - Additional Information (Detail)
46: R36 Helio vision acquisition - Additional Information HTML 58K
(Detail)
47: R37 Net Loss Per Share - Computation of Diluted HTML 30K
Weighted-Average Shares Outstanding (Detail)
48: R38 Cash, Cash Equivalents and Marketable Securities - HTML 62K
Schedule of Cash and Cash Equivalents (Detail)
49: R39 Cash, Cash Equivalents and Marketable Securities - HTML 24K
Additional Information (Detail)
50: R40 Fair Value Measurements - Schedule of Assets and HTML 44K
Liabilities Measured at Fair Value on Recurring
Basis (Detail)
51: R41 Prepaid Expenses and Other Current Assets - HTML 33K
Schedule of Prepaid Expenses and Other Current
Assets (Details)
52: R42 Accrued Expenses - Schedule of Accrued Expenses HTML 30K
(Detail)
53: R43 Credit Facility - Additional Information (Detail) HTML 79K
54: R44 Credit Facility - Schedule of Long-Term Debt HTML 33K
(Detail)
55: R45 Credit Facility - Schedule of Principal Payments HTML 28K
Incuding End of Term Charges (Detail)
56: R46 Stockholders' Equity - Additional Information HTML 42K
(Detail)
57: R47 Income Taxes - Additional Information (Detail) HTML 54K
58: R48 Income Taxes - Components of Deferred Tax Assets HTML 54K
and Liabilities (Detail)
59: R49 Income Taxes - Components of Income Tax Benefit HTML 32K
(Detail)
60: R50 Income Taxes - Summary of Statutory Tax Rates and HTML 40K
Effective Tax Rates (Detail)
61: R51 Stock Incentive Plan - Additional Information HTML 127K
(Detail)
62: R52 Stock Incentive Plan - Schedule of Stock-Based HTML 30K
Compensation Expense (Detail)
63: R53 Stock Incentive Plan - Summary of Stock Option HTML 72K
Activity (Detail)
64: R54 Stock Incentive Plan - Summary of Stock Option HTML 26K
Activity (Parenthetical) (Detail)
65: R55 Stock Incentive Plan - Schedule of Fair Value of HTML 51K
Stock Option Assumptions (Detail)
66: R56 Stock Incentive Plan - Summary of Activity HTML 59K
Relating to Restricted Stock Units (Detail)
67: R57 Stock Incentive Plan - Schedule of Fair Value of HTML 51K
Employee Stock Purchase Plan Assumptions (Detail)
68: R58 Stock Incentive Plan - Summary of Employee Stock HTML 40K
Purchase Plan Activity (Detail)
69: R59 Commitments and Contingencies - Additional HTML 38K
Information (Detail)
70: R60 Leases - Additional Information (Detail) HTML 33K
71: R61 Leases - Schedule of Maturities and Balance Sheet HTML 33K
Presentation of Lease Liabilities (Detail)
72: R62 Leases - Schedule of Future Minimum Payments Under HTML 33K
Non-Cancelable Operating Leases (Detail)
73: R63 Significant Agreements (Additional Information) HTML 38K
(Details)
75: XML IDEA XML File -- Filing Summary XML 142K
78: XML XBRL Instance -- aldx-20231231_htm XML 1.60M
74: EXCEL IDEA Workbook of Financial Report Info XLSX 141K
10: EX-101.SCH XBRL Taxonomy Extension Schema With Embedded XSD 3.15M
Linkbases Document -- aldx-20231231
76: JSON XBRL Instance as JSON Data -- MetaLinks 506± 787K
77: ZIP XBRL Zipped Folder -- 0000950170-24-027933-xbrl Zip 1.05M
| EX-21.1 |
Exhibit 21.1
SUBSIDIARIES OF ALDEYRA THERAPEUTICS, INC.
|
|
|
Name of Subsidiary |
|
Jurisdiction of Organization |
Helio Vision, LLC |
|
United States of America |
Helio Vision Germany GmbH |
|
Germany |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/07/24 Aldeyra Therapeutics, Inc. S-3 4:322K Donnelley … Solutions/FA |